Journal of Rheumatic Diseases

Scope & Guideline

Innovating research and practice in rheumatic diseases.

Introduction

Explore the comprehensive scope of Journal of Rheumatic Diseases through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Journal of Rheumatic Diseases in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2093-940x
PublisherKOREAN COLL RHEUMATOLOGY
Support Open AccessYes
CountrySouth Korea
TypeJournal
Convergefrom 2019 to 2024
AbbreviationJ RHEUMAT DIS / J. Rheum. Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRAEMIAN YONGSAN A BLDG 1917, 95 HANGANG-DAERO, YONGSAN-GU, SEOUL 04378, SOUTH KOREA

Aims and Scopes

The Journal of Rheumatic Diseases focuses on advancing knowledge in rheumatology through original research, reviews, and case reports. It aims to address various aspects of rheumatic diseases, including their epidemiology, pathophysiology, diagnosis, treatment, and patient outcomes.
  1. Clinical Research in Rheumatology:
    The journal publishes studies that explore the clinical characteristics, treatment responses, and outcomes of patients with various rheumatic diseases, contributing valuable data to the field.
  2. Innovative Therapeutic Approaches:
    A significant emphasis is placed on research involving new therapeutic strategies, including biologics, disease-modifying antirheumatic drugs (DMARDs), and emerging treatments for rheumatic conditions.
  3. Epidemiology and Disease Patterns:
    The journal includes epidemiological studies that investigate the prevalence, risk factors, and demographic characteristics of rheumatic diseases, particularly within specific populations.
  4. Pathophysiology and Mechanistic Studies:
    Research delving into the underlying biological mechanisms of rheumatic diseases, including genetic, immunological, and environmental factors, is a key focus area.
  5. Patient-Centered Outcomes and Quality of Life:
    The journal highlights studies that assess patient-reported outcomes, quality of life, and the psychosocial aspects of living with rheumatic diseases.
  6. Multidisciplinary Approaches:
    The journal recognizes the importance of multidisciplinary care in rheumatology, encouraging submissions that explore collaborations between rheumatologists, physiotherapists, and other healthcare providers.
Recent publications in the Journal of Rheumatic Diseases indicate a shift towards emerging themes that reflect current trends in rheumatology research. These themes are increasingly relevant to contemporary clinical practice and patient management.
  1. Biologics and Targeted Therapies:
    There is a growing body of research focusing on the effectiveness and safety of biologic therapies in various rheumatic diseases, indicating a trend towards personalized medicine and tailored treatment strategies.
  2. Impact of COVID-19 on Rheumatic Diseases:
    Research examining the implications of COVID-19 on patients with rheumatic diseases, including vaccination responses and disease management during the pandemic, has surged, reflecting the ongoing relevance of this global health crisis.
  3. Machine Learning and Predictive Analytics:
    The application of machine learning models and predictive analytics in rheumatology to forecast disease progression and treatment outcomes is emerging as a significant theme, showcasing the integration of technology in clinical practice.
  4. Patient Education and Empowerment:
    Studies emphasizing the importance of patient education, self-management, and shared decision-making in the management of rheumatic diseases are increasingly featured, highlighting a shift towards patient-centered care.
  5. Long-term Outcomes and Quality of Life Assessments:
    Research focusing on long-term outcomes, including renal prognosis and quality of life in patients with chronic rheumatic diseases, is becoming more prominent, reflecting a holistic approach to patient care.

Declining or Waning

While the Journal of Rheumatic Diseases has consistently focused on several core themes, some areas of research have shown a decline in prominence over the recent years, reflecting shifts in clinical interest and advancements in the field.
  1. Traditional Treatments and Conventional Therapies:
    Research focused solely on traditional DMARDs and older treatment modalities has decreased, likely due to the rise of biologics and targeted therapies, which are becoming the standard of care.
  2. Basic Science without Clinical Relevance:
    Studies that explore basic science aspects of rheumatology without a clear clinical application or relevance have become less frequent, as the journal aims to prioritize research that directly impacts patient care.
  3. Single-Center Studies:
    The prevalence of single-center studies has decreased as the journal favors larger, multi-center studies that provide more robust data and generalizability of findings.
  4. Non-Interventional Observational Studies:
    There appears to be a waning interest in non-interventional observational studies that do not offer new insights into treatment efficacy or patient outcomes, as the field moves towards more rigorous interventional research.

Similar Journals

ZEITSCHRIFT FUR RHEUMATOLOGIE

Empowering research and practice in rheumatic disease management.
Publisher: SPRINGER HEIDELBERGISSN: 0340-1855Frequency: 10 issues/year

ZEITSCHRIFT FUR RHEUMATOLOGIE, published by Springer Heidelberg, serves as a vital platform in the field of rheumatology, providing researchers, clinicians, and students with cutting-edge findings and discussions related to the diagnosis, treatment, and management of rheumatic diseases. Since its inception in 1974 and continuing until 2024, this journal retains its commitment to disseminating significant scientific work within this specialized domain. Although it is currently categorized in the Q4 quartile for Rheumatology and ranks 47 out of 73 in Scopus, reflecting its burgeoning presence, the journal is dedicated to evolving and gaining prominence in the academic community. By offering valuable insights and fostering scholarly discourse, ZEITSCHRIFT FUR RHEUMATOLOGIE plays a crucial role in advancing rheumatology research and enhancing patient care practices worldwide. The journal presents an opportunity for its readers to engage with contemporary studies and enrich their understanding of rheumatic ailments.

ANNALS OF THE RHEUMATIC DISEASES

Inspiring the Next Generation of Rheumatology Leaders
Publisher: BMJ PUBLISHING GROUPISSN: 0003-4967Frequency: 12 issues/year

ANNALS OF THE RHEUMATIC DISEASES, published by BMJ Publishing Group, stands as a leading academic journal in the realm of rheumatology and related fields, including biochemistry, immunology, and genetics. With an esteemed impact factor and a consistent ranking in the upper echelons of its category (Q1) as per the latest evaluations, this journal represents the forefront of research and innovation, fostering scientific advancement from 1945 to the present. As the top journal in the Medicine - Rheumatology category and achieving remarkable percentiles in various interdisciplinary categories, it serves as a critical platform for researchers, clinicians, and students dedicated to understanding and addressing rheumatic diseases. Although it does not currently offer open access, its rigorous peer-review process ensures the dissemination of high-quality research findings that are paramount in enhancing clinical practices and advancing scientific discourse. Readers can expect to be challenged and inspired by the breadth of studies and reviews that address the complexities of rheumatology and its intersecting scientific domains.

Modern Rheumatology

Advancing the Future of Rheumatology
Publisher: OXFORD UNIV PRESSISSN: 1439-7595Frequency: 6 issues/year

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.

BMC Rheumatology

Unlocking potential through open-access rheumatology research.
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

BMC Rheumatology is a vital open-access journal that has been disseminating high-quality research in the field of rheumatology since its inception in 2017. Published by Springer Nature, this journal provides a platform for original research, reviews, and clinical studies that advance the understanding and treatment of rheumatic diseases. With a commendable impact factor and ranked in the second quartile (Q2) for Rheumatology as of 2023, BMC Rheumatology exemplifies expertise, contributing significantly to the medical community's dialogue. Researchers, professionals, and students will find valuable insights within its pages, as it caters to a diverse audience through its commitment to open-access publishing, facilitating knowledge sharing without barriers. Based in the United Kingdom and indexed in Scopus, the journal continues to thrive with a steady convergence of academic excellence through 2024, making it an indispensable resource for those dedicated to advancing rheumatological science.

Reumatismo

Advancing knowledge in rheumatology for a healthier future.
Publisher: PAGEPRESS PUBLISSN: 0048-7449Frequency: 4 issues/year

Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.

European Journal of Rheumatology

Bridging Science and Practice in Rheumatology
Publisher: AVESISSN: 2147-9720Frequency: 4 issues/year

European Journal of Rheumatology is a premier, peer-reviewed journal that has been paving the way for innovative research and in-depth analysis in the field of rheumatology since its launch. Published by AVES, this Open Access journal has been accessible to researchers, professionals, and students worldwide since 2014, promoting the sharing of valuable knowledge on rheumatic diseases and their treatment. With an ISSN of 2147-9720 and an E-ISSN of 2148-4279, it provides a prominent platform for groundbreaking studies and clinical evaluations that bridge scientific discovery with practical application. The journal’s mission is to enhance the understanding of rheumatological conditions and facilitate advancements in therapeutic strategies, making it an essential resource for anyone devoted to the improvement of patient care in this dynamic field. The European Journal of Rheumatology is committed to upholding the highest standards of scholarly publishing and aims to foster collaboration among researchers and practitioners across Europe and beyond.

Rheumatology & Autoimmunity

Exploring the frontiers of autoimmune research.
Publisher: WILEYISSN: 2767-1410Frequency: 4 issues/year

Rheumatology & Autoimmunity, published by WILEY, is an emerging academic journal that delves into the intricacies of rheumatological diseases and autoimmune disorders, providing a critical platform for researchers and practitioners within the field. With an ISSN of 2767-1410 and E-ISSN 2767-1429, the journal aims to disseminate cutting-edge research in both clinical and laboratory settings, enhancing knowledge and understanding among professionals and scholars. Although currently classified in Q4 for Immunology and Allergy, and Q3 for Internal Medicine and Rheumatology as of 2023, the journal is positioned for growth and greater visibility in the scientific community. The three-year publishing span from 2021 to 2024 signifies a commitment to addressing contemporary issues and fostering collaboration among various disciplines related to immunology. As an open access journal, it provides wide accessibility, ensuring that groundbreaking research is available to a broad audience. This journal is poised to become a vital resource for those dedicated to advancing the understanding and treatment of autoimmune conditions.

Lancet Rheumatology

Unveiling the latest breakthroughs in rheumatological research.
Publisher: ELSEVIERISSN: 2665-9913Frequency: 12 issues/year

The Lancet Rheumatology, published by Elsevier, is a premier academic journal dedicated to advancing the understanding of rheumatology and immunological diseases. Launched in 2019, this esteemed publication has quickly become a leading source of research, achieving an impressive Q1 ranking in both the fields of Rheumatology and Immunology as of 2023. With Scopus rankings placing it at #2 out of 73 in Medicine - Rheumatology and #6 out of 233 in Medicine - Immunology and Allergy, the journal serves as an essential platform for disseminating high-quality, peer-reviewed articles that address the latest findings and clinical practices in these domains. The journal, accessible in print and online, is committed to fostering knowledge and collaboration among researchers, healthcare professionals, and students alike, making it an invaluable resource for those seeking to deepen their expertise in rheumatology and its interrelated fields.

Lupus Science & Medicine

Innovative research, transformative treatments in lupus care.
Publisher: BMJ PUBLISHING GROUPISSN: 2053-8790Frequency: 1 issue/year

Lupus Science & Medicine is a leading open-access journal published by the BMJ Publishing Group, dedicated to advancing the understanding and treatment of lupus and related autoimmune diseases. Since its establishment in 2014, the journal has fostered an academic environment for researchers, healthcare professionals, and students, providing a platform for high-quality, evidence-based studies. With a notable impact in the fields of immunology and rheumatology, it currently holds a Q1 ranking in Rheumatology and Medicine (miscellaneous) and Q2 in Immunology, reflecting its significant contribution to these vital areas of medical research. The journal is indexed in Scopus, with a commendable rank in the 67th percentile for Rheumatology, making it a valuable resource for those seeking the latest insights into lupus management and treatment. The journal emphasizes the importance of open access, ensuring that research findings are widely available to enhance global knowledge and collaboration in the fight against lupus.

Indian Journal of Rheumatology

Empowering rheumatology research for a healthier tomorrow.
Publisher: SAGE PUBLICATIONS INCISSN: 0973-3698Frequency: 4 issues/year

Welcome to the Indian Journal of Rheumatology, a premier scholarly platform dedicated to advancing research and clinical practice in the field of rheumatology. Published by SAGE Publications Inc., this journal has been providing open access to its valuable content since 2006, promoting the dissemination of knowledge in India and beyond. As a voice in the rheumatology community, the journal addresses a wide range of topics including epidemiology, diagnostics, treatment strategies, and patient care in rheumatic diseases. Despite being classified in the Q4 category of the 2023 Scopus rankings, with a current position of Rank #57 among 73 journals, it serves as an essential resource for researchers, healthcare professionals, and students seeking to stay updated with the latest developments. The journal is committed to fostering scholarly dialogue and facilitating access to research that influences practice and improves patient outcomes in rheumatologic care.